Trials / Completed
CompletedNCT02770313
Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Intermountain Health Care, Inc. · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to determine how effective repeated fasting over 26 weeks (6 months) is at improving risk parameters that are surrogate endpoints for cardiovascular diseases, metabolic dysregulation and cognitive impairments. Subjects will be randomized 1:1 to water-only fasting or to their ad libitum usual diet, with randomization performed within strata based on fasting history (≤180 hours or 181-720 hours of total fasting for \>12 consecutive hours per episode in the previous two years). Subjects will be assessed at 4, 13 and 26 weeks following randomization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Intermittent Fasting | Subjects allocated to the fasting arm will undergo a fasting regimen of twice-per-week 24-hour fasting on non-consecutive days during the first 4 weeks of the study, then once-per-week 24-hour fasting during the rest of the study (22 weeks). |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2020-02-19
- Completion
- 2020-02-19
- First posted
- 2016-05-12
- Last updated
- 2020-07-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02770313. Inclusion in this directory is not an endorsement.